Bausch & Lomb (BLCO) Shares Outstanding (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Shares Outstanding (Entity) came in at $357.1 million in Q2 2026, up 0.92% YoY from $353.8 million in Q2 2025, and little changed on a QoQ basis from $356.4 million in Q1 2026.
Bausch & Lomb (BLCO) Shares Outstanding (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Shares Outstanding (Entity) data on file, last reported at $357.1 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 0.92% year-over-year to $357.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $357.1 million (up 0.92% YoY) and the FY2025 annual result came in at $354.2 million, up 0.51% from the prior year.
- Shares Outstanding (Entity) held at $357.1 million in Q2 2026, from $356.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $357.1 million in Q2 2026 to a low of $350.0 million in Q1 2022.
- A 5-year average of $352.2 million and a median of $351.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) changed 0.0% — and 2026, when it rose 0.92%.
- Tracing BLCO's Shares Outstanding (Entity) over 5 years: stood at $350.2 million in 2022, then rose by 0.21% to $350.9 million in 2023, then grew by 0.42% to $352.4 million in 2024, then grew by 0.51% to $354.2 million in 2025, then gained by 0.8% to $357.1 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $357.1 million (Q2 2026), $356.4 million (Q1 2026), and $354.2 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 357.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 357.10 Mn |
| Mar 31, 2026 | 355.20 Mn |
| Dec 31, 2025 | 353.80 Mn |
| Sep 30, 2025 | 354.20 Mn |
| Jun 30, 2025 | 353.70 Mn |
| Mar 31, 2025 | 352.80 Mn |
| Dec 31, 2024 | 351.80 Mn |
| Sep 30, 2024 | 351.90 Mn |
| Jun 30, 2024 | 351.80 Mn |
| Mar 31, 2024 | 351.10 Mn |
| Dec 31, 2023 | 350.50 Mn |
| Sep 30, 2023 | 350.80 Mn |
| Jun 30, 2023 | 350.50 Mn |
| Mar 31, 2023 | 350.00 Mn |
| Dec 31, 2022 | 350.00 Mn |
| Sep 30, 2022 | 350.00 Mn |
| Jun 30, 2022 | 350.00 Mn |
| Mar 31, 2022 | 350.00 Mn |
| Dec 31, 2021 | 350.00 Mn |
| Sep 30, 2021 | 350.00 Mn |